A method for signal enhancement in a colorimetric, nonradioactive and quantitative microplate hybridization assay is described. The signal enhancement provides for the direct detection of viral DNA in serum samples without the use of DNAamplification.
The microplate hybridization assay (MHA) was developed for the detection of amplified DNA sequences. The assay, as described by Rapier et al. (5) and based on Cook et al. (1) , uses an oligonucleotide probe affixed to a microplate well (capture probe) to remove complementary DNA from solution. The captured DNA is then hybridized to a second oligonucleotide probe carrying a poly(T) tail on its 3 ′ terminus (signal probe). The bound poly(T) is then hybridized with a biotin-modified poly(dA) (BioBridge ® labeling molecule; Enzo Diagnostics, Farmingdale, NY, USA), and the bound biotin is detected with a complex of biotinylated horseradish peroxidase and streptavidin (Detek ® hrp; Enzo Diagnostics).
As a means of applying the MHA for direct detection of DNA sequences, we developed an enhanced microplate hybridization assay (EMHA) by the application of antibody-enhanced signal amplification. Here, the bound biotin is detected by a double-antibody procedure in which rabbit anti-biotin binds the biotin moieties of the hybridized BioBridge molecule, and biotinylated goat anti-rabbit IgG binds the rabbit anti-biotin. The biotins contained in the second antibody are then detected with Detek hrp. Colorimetric determination is by color development with H 2 O 2 and tetramethylbenzidine, with color conversion by the addition of H 2 SO 4 (horseradish peroxidase generates a blue color from the H 2 O 2 substrate and tetramethylbenzidine chromogen; H 2 SO 4 addition converts it to yellow which is read at 450 nm).
While the MHA has been used for the detection of amplified DNA (5), we have applied the EMHA to the direct detection of virus DNA sequences. For the direct detection of hepatitis B virus (HBV) DNA, for example, we utilized a capture probe of 50 nucleotides (bases 1941 to 1990) (2) . It was prepared by standard methods using an Applied Biosystems instrument (Model 380B; PE Applied Biosystems, Foster City, CA, USA) and purified by high-performance liquid chromatography. The capture probe was affixed to microplate wells (Immulon ® 2 flat-bottom Dividastrips ® ; Dynatech, Chantilly, VA, USA) (6) . A signal probe of 30 bases (bases 2006-2035) (2) was terminally labeled with poly(T) by using terminal deoxynucleotidyl transferase (1). The enhanced microplate assay was performed as described below.
The oligonucleotide probes used in this multi-hybrid microplate hybridization system are more suitable for hybridization to the short fragments of DNA generated through amplification schemes such as PCR than they are for longer DNA segments such as plasmid or virus DNA. Thus, a method for release and partial fragmentation of the hepatitis B viral DNA in serum was developed. Serum specimens (125 µ L) were added to an equal volume of acidified detergent (0.4 NHCl, 2.0% Triton ® X-100) and were incubated at 37°C for 5 min. The released, partially depurinated DNA was denatured by the addition of 50 µ L of 3 NNaOH, after which the samples were incubated at 65°C for 5 min to fragment the DNA at the sites of depurination. For capture hybridization, 100 µ L of treated samples were added to duplicate capture wells containing 80 µ L of a hybridization solution (66% deionized 346BioTechniques
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Christine L. Brakel Enzo Diagnostics, Inc., Farmingdale, NY, USA BioTechniques 22:346-348 (February 1997) formamide, 0.1 M NaCl, 0.24 M Trizma ® HCl [Sigma Chemical, St. Louis, MO, USA], 0.01 M EDTA, 1% Triton X-100, 5% dextran sulfate and 0.24 NHCl). Capture hybridization was allowed to proceed at room temperature with vigorous shaking on a microplate shaker (Dynatech Minishaker) for 3 h, which could be extended for 20-24 h without increase or decrease in signal intensity. All subsequent steps of the procedure were performed at room temperature with vigorous shaking with the exception of color development, which was done without shaking. Following capture hybridization, the microwells were emptied, and the excess liquid was blotted by tamping the wells several times on a stack of paper towels. The microwells were then hybridized for 15 min with 50 µ L of the signal probe solution containing 33% deionized formamide, 0.15 M NaCl, 0.12 M HEPES, 5 mM EDTA, 1% Triton X-100, 2.5% dextran sulfate, 0.001% phenol red indicator and 0.2 µ g/mL of T-tailed signal oligonucleotide.
The wells were washed four times with 200 µ L of wash buffer (0.2 ×standard saline citrate [SSC], 0.1% Triton X-100) and were then incubated with shaking for 10 min with 50 µ L of linker (BioBridge in 1.2 × SSC, 0.1% Triton X-100, 5.0 mM EDTA). The wells were again washed four times with the wash buffer and were then incubated (20 min, with shaking) and washed (4 times) between the successive incubations with rabbit anti-biotin, biotinylated goat anti-rabbit IgG (Pierce, Rockford, IL, USA) and, finally, Detek hrp. Each of the detection reagents was freshly diluted to an appropriate working concentration using phosphate-buffered saline containing 0.3% gelatin, 10 mM EDTA, 0.025% Triton X-100 and 0.01% thimerosal (Sigma Chemical) preservative.
Following incubation with Detek hrp, the microwells were washed five times with the wash buffer, and the color was developed for 15 min (without shaking) with 100 µ L of reaction solution containing 0.1 M citrate phosphate buffer, pH 5.3, 0.025% H 2 O 2 and 0.5 mg/mL tetramethylbenzidine (Aldrich Chemical, Milwaukee, WI, USA). Color development was terminated with simultaneous color conversion from blue to yellow by the addition of 100 µ L of 2 NH 2 SO 4 . Absorbance at 450 nm was determined using a Diamedix (Miami, FL, USA) Microassa y ™BP-12 bichromatic strip reader.
A comparison of signal generation from the MHA and the EMHA in detection of hepatitis B virus DNA sequences is shown in Figure 1 . Heat-inactivated fetal bovine serum (Life Technologies, Gaithersburg, MD, USA) was used as a negative control after the addition of EDTA to 5 mM and NaN 3 to 0.1% (vol/vol). Varying concentrations of HBV DNA were prepared by adding increasing amounts of closed circular recombinant plasmid DNA (1) to the negative control serum. The EMHA is approximately 8-fold to 10-fold more sensitive than the standard assay, giving a sensitivity of 10-20 pg/42 µ L ( = 240-480 pg/mL of plasmid DNA) ( Table 1) .
The effectiveness of the EMHA for direct detection of HBV DNA was tested in sera that were positive for hepatitis B surface antigen. As a means of assessing the detection efficiency, a commercially available assay, the Abbott Genostics Hybridization Assay for Hepatitis B DNA (Abbott Diagnostics, Abbott Park, IL, USA), was used as a standard, whereby 50 samples (46 clinical specimens and 4 titration standards) were sent to a regional testing laboratory for assay by the Abbott test. The 46 samples included 37 that were positive for hepatitis surface antigen. Nine of the 37 were positive for HBV DNA by the EMHA. Of these 9, 7 were positive by the Abbott test. Furthermore, 2 of the hepatitis B surface antigen (HBsAg)-positive samples that were negative by the EMHA gave positive results in the Abbott assay. None of the 9 HBsAg-negative specimens produced a positive signal by either the EMHA or by the Abbott test. Plotting the quantitative results for the Abbott test vs. the A 450 readings from the EMHA for all 50 specimens demonstrates the excellent correlation between the two assay results (Figure 2) . This also provides a confirmation for the validity of HBV DNA quantification by the EMHA.
Thus, antibody-enhanced signal generation extends the usefulness of microplate hybridization assays. In fact, HBV DNA in serum samples can be detected without the application of DNA amplification procedures (3, 4) and detection efficiency is comparable to that obtained using a radioactive probe. Negative control serum and HBV plasmid DNA-spiked negative control serum were assayed as described. Samples (125 µ L) were treated with specimen digestion reagent, denatured with NaOH and then hybridized as described. The hybridized samples were then developed without antibody enhancement (diamonds) or with antibody enhancement (squares).
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